ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      83.12
      0.43%
      Bitcoin
      63,795.52
      -0.15%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. IntelliPharmaCeutics International Inc (QB) (IPCIF)

      7. IntelliPharmaCeutics International Inc (QB) (IPCIF) News

      IPCIF

      IntelliPharmaCeutics (QB) (IPCIF)

      IntelliPharmaCeutics International Inc (QB)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:IPCIF
      DateTimeSourceHeadlineSymbolCompany
      03/07/20243:21PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      02/14/20242:48PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      10/16/20235:23PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      10/06/202311:33AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      10/06/202311:33AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      09/26/20235:29PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      09/26/20235:23PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      07/21/20225:29PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      05/27/20225:13PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      04/29/202211:44AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      03/01/20228:05AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      03/01/20226:23AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      02/15/20226:31AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      02/04/20224:43PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      01/06/20225:20PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      07/15/20214:46PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      04/22/20217:57AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      04/14/20217:52AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      03/31/20215:32PMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      03/01/20218:40AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      03/01/20218:32AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      02/16/20215:36PMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      12/15/20205:31PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      11/24/20206:02AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      07/15/20205:31PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      07/02/20202:41PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      05/29/20205:31PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      04/10/20206:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      03/30/20205:30PMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
      02/28/20204:48PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:IPCIFIntelliPharmaCeutics International Inc (QB)
       Showing the most relevant articles for your search:USOTC:IPCIF